Effects of malnutrition on cytochrome P450 1A2 activity in elderly patients

Therapie

Volumn 59, Issue 2, 2004, Pages 247-251

  Hamon Vilcot, Brigitte ^a   Simon, Tabassome ^b   Becquemont, Laurent ^b   Poirier, Jean Marie ^b   Piette, François ^a   Jaillon, Patrice ^b  

^a HÔPITAL CHARLES FOIX   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Caffeine; Cytochrome P450 1A2; Elderly patients; Human; Malnutrition

Indexed keywords

ALBUMIN; CAFFEINE; CYTOCHROME P450 1A2; PARAXANTHINE;

AGED; ALBUMIN BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ELDERLY CARE; ENZYME ACTIVITY; EVALUATION; FEMALE; HUMAN; INSTITUTIONALIZATION; KIDNEY CLEARANCE; MALE; MALNUTRITION; METABOLIC DISORDER; NUTRITIONAL STATUS; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 3543052224     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2004048     Document Type: Conference Paper

References (19)

1. Dirren H, Decarli B, Lesourd B, et al. Nutritional status: haematology and albumin. Euronut SENECA investigators. Eur J Clin Nutr 1991; 45 (3): 43-52
2. Lesourd B. Protein undernutrition as the major cause of decreased immune function in the elderly: clinical and functional implications. Nutr Rev 1995; 53: S86-91
3. Durnas CH, Loi CM, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990; 19 (5): 359-89
4. Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly. Clin Pharmacokinet 1997; 33 (4): 302-12
5. Loi CM, Vestal RE. Drug metabolism in the elderly. Pharmacol Ther 1988; 36 (1): 131-49
6. O'Mahony MS, Woodhouse KW. Age. environmental factors and drug metabolism. Pharmacol Ther 1994; 61: 279-87
7. Guenguerich FP. Human cytochrome P450 enzymes. Life Sci 1992; 50: 1471-8
8. Fuhr U, Rost KL. Simple and reliable CYP 1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva. Pharmacogenetics 1994; 4: 109-16
9. Berthou F, Goasduff T, Lucas D, et al. Interaction between two probes used for phenotyping cytochrome P450 1A2 (caffeine) and P450 2E1 (chlorzoxazone) in humans. Pharmacogenetics 1995; 5: 72-9
10. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
11. Salako LA, Sowunmi A, Akinbami FO. Pharmacokinetics, of quinine in African children suffering from kwashiorkor. Br J Clin Pharmacol 1989; 28: 197-201
12. Treluyer JM, Roux A, Mugnier C, et al. Metabolism of quinine in children with global malnutrition. Pediatr Res 1996; 4: 558-63
13. Krishnaswamy K. Drug metabolism and pharmacokinetics in malnourished children. Clin Pharmacokinet 1989; 17: 68-88
14. Tranvouez JL, Lerebours E, Chretien P, et al. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation. Am J Clin Nutr 1985; 41: 1257-64
15. Griep MI, Mets TF, Collys K, et al. Risk of malnutrition in retirement homes elderly persons measured by the "mini-nutritional assessment". J Gerontol A Biol Sci Med Sci 2000; 55: 57-63
16. Bonati M, Latini R, Galletti F, et al. Caffeine disposition after oral doses. Clin Pharmacol Ther 1982; 32: 98-106
17. Sotaniemi EA, Arranto AJ, Pelkonen O, et al. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther 1997; 61: 331-9
18. Simon T, Becquemont L, Hamon B, et al. Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers. Br J Clin Pharmacol 2001; 52: 601-4
19. Chung WG, Kang JH, Park CS, et al. Effect of age and smoking on in vivo CYP 1A2, flavin-containing mono-oxygenase, and xanthine oxydase activites in Koreans: determination by caffeine metabolism. Clin Pharmacol Ther 2000; 67: 258-66